Adiponectin and resistin in the neonatal rat: effects of dexamethasone and hypoxia.
Hypoxia is a common neonatal stress that induces insulin resistance and a decrease in body weight gain. Dexamethasone is often used to treat neonatal cardiopulmonary disease, and also leads to insulin resistance and a decrease in body weight gain. The current study addressed the hypothesis that serum concentrations of the adipokines adiponectin and/or resistin are altered during hypoxia and/or dexamethasone therapy in neonatal rats. Rat pups with their lactating dams were exposed to hypoxia (11% O2) from birth and treated with a tapering regimen of dexamethasone from postnatal day (PD) 3-6. Serum adiponectin and resistin were measured on PD7. Hypoxia and dexamethasone independently decreased body weight gain and increased adiponectin levels. The combination of hypoxia and dexamethasone did not further increase adiponectin. Dexamethasone caused a small increase in resistin in normoxic pups, which may facilitate the hyperinsulemic- normoglycemic state we previously described. We also conclude that adiponectin is increased during hypoxia in response to a decrease in the sensitivity to insulin.
Raff
Hershel
H
Endocrine Research Laboratory, St. Luke's Medical Center, Milwaukee, WI 53215, USA. hraff@mcw.edu
Bruder
Eric D
ED
D052242:Adiponectin / Q000097:blood*; D000818:Animals; D000831:Animals, Newborn / Q000097:blood*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000097:blood; D050197:Atherosclerosis / Q000517:prevention & control; D001835:Body Weight / Q000187:drug effects; D003907:Dexamethasone / Q000009:adverse effects*; D000860:Hypoxia / Q000097:blood*; D007333:Insulin Resistance; D051381:Rats; D017207:Rats, Sprague-Dawley; D052243:Resistin / Q000097:blood*
D052242:Adiponectin; D000894:Anti-Inflammatory Agents, Non-Steroidal; D052243:Resistin; C499622:Retn protein, rat; D003907:Dexamethasone